Search results for "burden"

showing 10 items of 393 documents

Blue-light imaging compared with high-definition white light for real-time histology prediction of colorectal polyps less than 1 centimeter: a prospe…

2019

Blue-light imaging (BLI) is a new chromoendoscopy technique, potentially useful for differentiating neoplastic from nonneoplastic lesions. The present study was aimed at comparing BLI with high-definition white light (HDWL) in the real-time histology prediction of colon polyps 10 mm.Consecutive outpatients undergoing colonoscopy with the ELUXEO 7000 endoscopy platform and 760 series video colonoscopes (Fujifilm Co, Tokyo, Japan) who had at least 1 polyp 10 mm were randomized to BLI or HDWL for polyp characterization. The accuracy of high-confidence real-time histology prediction (adenoma vs not adenoma) by either BLI or HDWL for polyps 10 mm (primary end-point) and diminutive (≤5 mm) polyps…

MaleColonoscopyColonic PolypsSensitivity and SpecificityChromoendoscopy03 medical and health sciencesAdenomatous PolypsNarrow Band Imaging0302 clinical medicineWhite lightMedicineHumansRadiology Nuclear Medicine and imagingProspective randomized studyBlue lightAgedCentimetermedicine.diagnostic_testbusiness.industryGastroenterologyIntestinal PolypsHistologyColonoscopyMiddle Ageddigestive system diseasesEndoscopyTumor Burden030220 oncology & carcinogenesis030211 gastroenterology & hepatologyFemalebusinessNuclear medicineColorectal NeoplasmsGastrointestinal endoscopy
researchProduct

Computed tomography coronary angiography plaque burden in patients with suspected coronary artery disease.

2009

Purpose To determine the relationship between established cardiovascular risk factors, clinical presentation and the extent of coronary artery disease (CAD), as described with computed tomography coronary angiography. Material and methods In this cross-sectional study, we included 567 symptomatic individuals without a history of CAD who consecutively underwent 64-slice computed tomography coronary angiography for evaluation of suspected CAD. We analyzed the prevalence of CAD depending on sex, age, symptoms and risk factors. Results A total of 8542 segments were analyzed. No evidence of CAD was observed in 225 patients (40%), nonsignificant CAD in 221 patients (39%) and significant CAD (lumi…

MaleCoronary angiographymedicine.medical_specialtyMultivariate analysisComputed tomographyCADCoronary Artery DiseaseDiseaseCoronary AngiographyCoronary artery diseaseRisk FactorsInternal medicineEpidemiologymedicineHumansIn patientcardiovascular diseasesAgedmedicine.diagnostic_testbusiness.industryGeneral MedicineMiddle Agedmedicine.diseaseplaque burdenCross-Sectional StudiesMultivariate AnalysisCardiologyFemaleTomography X-Ray ComputedCardiology and Cardiovascular Medicinebusiness
researchProduct

Global, regional, and national burden of stroke, 1990-2016

2019

Background: Stroke is a leading cause of mortality and disability worldwide and the economic costs of treatment and post-stroke care are substantial. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) provides a systematic, comparable method of quantifying health loss by disease, age, sex, year, and location to provide information to health systems and policy makers on more than 300 causes of disease and injury, including stroke. The results presented here are the estimates of burden due to overall stroke and ischaemic and haemorrhagic stroke from GBD 2016. Methods: We report estimates and corresponding uncertainty intervals (UIs), from 1990 to 2016, for incidence, preval…

MaleCost effectivenessIMPACTGlobal HealthGUIDELINES3124 Neurology and psychiatryBrain IschemiaGlobal Burden of DiseaseCOST-EFFECTIVENESS0302 clinical medicineRisk FactorsGlobal healthPrevalenceMedicine030212 general & internal medicineStrokePOPULATIONAged 80 and overRISKeducation.field_of_studyIncidence (epidemiology)Mortality rateIncidenceAge FactorsMiddle AgedPREVALENCEStrokeFemaleLife Sciences & BiomedicineIntracranial HemorrhagesAdultPopulationClinical Neurology03 medical and health sciencesHumanseducationAgedScience & TechnologyNeurology & Neurosurgerybusiness.industry3112 NeurosciencesKlinisk medicin1103 Clinical Sciencesmedicine.diseaseGBD 2016 Stroke CollaboratorsVerbal autopsyTRANSIENT ISCHEMIC ATTACKYears of potential life lostSocioeconomic FactorsHuman medicineNeurosciences & NeurologyNeurology (clinical)Clinical Medicine1109 NeurosciencesbusinessPRIMARY PREVENTION030217 neurology & neurosurgeryDemographyRCLancet Neurology
researchProduct

Epidemiology of Chronic Pain in the Latium Region, Italy. a Cross-sectional Study on the Clinical Characteristics of Patients Attending Pain Clinics

2019

In Italy, chronic pain affects more than a quarter of the population, whereas the average European prevalence is 21%. This high prevalence might be due to the high percentage of Italian people who do not receive treatment, even after the passing of law 38/2010 (the right to access pain management in Italy), which created a regional network for the diagnosis and treatment of noncancer chronic pain. Italian epidemiologic studies on chronic pain are scanty, and this observational, multicenter, cross-sectional study is the first to investigate the clinical characteristics of patients who attended the pain management clinics in the Latium Region, Italy, for the management of their noncancer chro…

MaleCross-sectional studyIMPACTEpidemiology chronic pain pain clinicschronic non-malignant pain0302 clinical medicinenursingRisk FactorsEpidemiologyPrevalence030212 general & internal medicineeducation.field_of_studyHigh prevalence030504 nursingChronic painMiddle AgedSettore MED/45 - Scienze Infermieristiche Generali Cliniche E PediatricheAREItalygender differencesFemaleepidemiologyHEALTH0305 other medical scienceBURDENPRESENTEEISMchronic painpain management; chronic pain; gender differences; chronic non-malignant pain; epidemiologyAdultmedicine.medical_specialtyPopulation03 medical and health sciencesPREVALENCE IMPACT BURDENARE DISABILITY MANAGEMENT HEALTH PRESENTEEISM SEVERITY ADULTSInternal medicinemedicineMANAGEMENTHumanseducationAgedAdvanced and Specialized Nursingbusiness.industryDISABILITYADULTSPain managementmedicine.diseasePain ClinicsSEVERITYCross-Sectional Studiespain managementPain ClinicsObservational studybusiness
researchProduct

Lifetime self-reported arthritis is associated with elevated levels of mental health burden: A multi-national cross sectional study across 46 low- an…

2017

Population-based studies investigating the relationship of arthritis with mental health outcomes are lacking, particularly among low- and middle-income countries (LMICs). We investigated the relationship between arthritis and mental health (depression spectrum, psychosis spectrum, anxiety, sleep disturbances and stress) across community-dwelling adults aged ≥18 years across 46 countries from the World Health Survey. Symptoms of psychosis and depression were established using questions from the Mental Health Composite International Diagnostic Interview. Severity of anxiety, sleep problems, and stress sensitivity over the preceding 30 days were self-reported. Self-report lifetime history of a…

MaleCross-sectional studyPsychological interventionArthritisComorbidityGlobal Health0302 clinical medicineQUALITY-OF-LIFEOdds RatioPrevalencePublic Health Surveillance030212 general & internal medicineGENERAL-POPULATIONINFECTED PATIENTSeducation.field_of_studyMultidisciplinaryQRMiddle Aged3. Good healthMental HealthDEPRESSIVE SYMPTOMSIncomeMedicineAnxietyFemalemedicine.symptomAdultmedicine.medical_specialtySciencePopulationArticleYoung Adult03 medical and health sciencesmedicineHumansPsychiatryeducationDeveloping CountriesSLEEP PROBLEMSbusiness.industryArthritisOdds ratioGLOBAL BURDENSTRESS SENSITIVITYmedicine.diseaseComorbidityMental healthPSYCHOTIC EXPERIENCESRHEUMATOID-ARTHRITISCross-Sectional StudiesPHYSICAL-ACTIVITYSocial ClassSelf Reportbusiness030217 neurology & neurosurgeryScientific Reports
researchProduct

The global burden of cancer attributable to risk factors, 2010–19 : A systematic analysis for the Global Burden of Disease Study 2019

2022

Background: Understanding the magnitude of cancer burden attributable to potentially modifiable risk factors is crucial for development of effective prevention and mitigation strategies. We analysed results from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 to inform cancer control planning efforts globally. Methods: The GBD 2019 comparative risk assessment framework was used to estimate cancer burden attributable to behavioural, environmental and occupational, and metabolic risk factors. A total of 82 risk-outcome pairs were included on the basis of the World Cancer Research Fund criteria. Estimated cancer deaths and disability-adjusted life-years (DALYs) in 20…

MaleDEATHSDALY cancer risk factorsMedizinsystematic analysisGlobal HealthRisk AssessmentCancer preventionGlobal Burden of DiseaseRC0254Risk-attributable cancer deathsSDG 3 - Good Health and Well-beingRA0421Risk FactorsRA0421 Public health. Hygiene. Preventive MedicineQuality-Adjusted Life YearNeoplasmscancerHumansGlobal Burden of Disease StudyUKMedicine(all)MCCRC0254 Neoplasms. Tumors. Oncology (including Cancer)Risk FactorSmokingCOVID-193rd-DASGeneral MedicineDisability-adjusted life-yearsSOCIAL DETERMINANTSRisk assessmentsrisk factorCardiovascular and Metabolic Diseases3121 General medicine internal medicine and other clinical medicineOBESITYCancer burden/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingNeoplasmFemaleLIFE-STYLEQuality-Adjusted Life YearsHEALTHRAHumanRC
researchProduct

The use of national administrative data to describe the spatial distribution of in-hospital mortality following stroke in France, 2008-2011.

2016

International audience; Background: In the context of implementing the National Stroke Plan in France, a spatial approach was used to measure inequalities in this disease. Using the national PMSI-MCO databases, we analyzed the in-hospital prevalence of stroke and established a map of in-hospital mortality rates with regard to the socio-demographic structure of the country.Methods: The principal characteristics of patients identified according to ICD10 codes relative to stroke (in accordance with earlier validation work) were studied. A map of standardized mortality rates at the level of PMSI geographic codes was established. An exploratory analysis (principal component analysis followed by …

MaleDatabases FactualBusiness Management and Accounting(all)Health informatics0302 clinical medicineEpidemiology030212 general & internal medicineHospital MortalityStrokeAged 80 and overGeographyMortality rategbd 2013Middle Aged3. Good healthStrokeIn-hospital mortalityFemaleFranceComputer Science(all)trendsAdultmedicine.medical_specialtyGeneral Computer ScienceHealth geographyunited-statesprevalenceMEDLINEContext (language use)03 medical and health sciences[ SDV.MHEP ] Life Sciences [q-bio]/Human health and pathologymedicineHumanscareAgedDemographydiseasebusiness.industrycigarette-smokingPublic healthResearchglobal burdenPublic Health Environmental and Occupational HealthPMSImedicine.diseaseyoung-adultsGeneral Business Management and Accountingtransient ischemic attackbusiness030217 neurology & neurosurgery[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologyDemographyInternational journal of health geographics
researchProduct

Cancer costs and outcomes for common cancer sites in the Finnish population between 2009–2014

2018

The cost of cancer and outcomes of cancer care have been discussed a lot since cancer represents 3-6% of total healthcare costs and cost estimations have indicated growing costs. There are studies considering the cost of all cancers, but studies focusing on the cost of disease and outcomes in most common cancer sites are limited. The objective of this study was to analyze the development of the costs and outcomes in Finland between 2009 and 2014 per cancer site.The National cost, episode and outcomes data were obtained from the National register databases based on International Statistical Classification of Diseases (ICD)-10 diagnosis codes. Cost data included both the direct and indirect c…

MaleENGLANDTreatment outcomesairaalahoitocosts0302 clinical medicineFinnish populationavohoitoNeoplasmsHealth careRegistries030212 general & internal medicineta512Finlandhealth care economics and organizationsta316Aged 80 and overnon-institutional careNeoplasms therapyta3142Health Care CostsHematologyGeneral MedicineMiddle Agedkustannukset3. Good healthSurvival RateTreatment OutcomeOncology030220 oncology & carcinogenesisNORWAYSURVIVALHealth ResourcessyöpätauditFemaleSick LeaveCOUNTRIESAdultsairaalatmedicine.medical_specialtyMEDLINEUNITED-STATEShoito03 medical and health sciencesBreast cancerSuomiECONOMIC BURDENmedicineBREAST-CANCERHumansRadiology Nuclear Medicine and imagingIntensive care medicineSurvival rateAgedbusiness.industryCancercancerous diseasesCAREta3122medicine.diseasehospitalsbusinesshospital careActa Oncologica
researchProduct

The role of mind theory in patients affected by neurodegenerative disorders and impact on caregiver burden

2020

Abstract Background Theory of Mind (ToM) is defined as the ability to understand mental and emotional state. This ability is assessed also in neurodegenerative disease. Few studies have investigated the impact that social cognition of patients could have on caregiver burden. The aim of this study was to investigate a possible correlation in level of social cognition impairment between patients with different neurodegenerative disorders and their caregivers with possible impact on caregivers burden. Methods we enrolled 48 patients with dementia divided in different groups: Fronto-Temporal Dementia (FTD), Alzheimer Disease (AD), and Mild Cognitive Impairment (MCI) and also the three groups of…

MaleEmotionsTheory of MindDiseaseFronto-temporal dementia03 medical and health sciences0302 clinical medicineSocial cognitionAlzheimer DiseasePhysiology (medical)Theory of mindmental disordersActivities of Daily Livingmedicine80 and overDementiaHumansIn patientCognitive DysfunctionAlzheimer disease; Caregiver; Dementia; Fronto-temporal dementia; Mild cognitive impairment; Theory of mind; Activities of Daily Living; Aged; Aged 80 and over; Alzheimer Disease; Caregivers; Cognitive Dysfunction; Emotions; Female; Frontotemporal Dementia; Humans; Male; Middle Aged; Neurodegenerative Diseases; Theory of MindAgedAged 80 and overbusiness.industryMild cognitive impairmentNeurodegenerative DiseasesGeneral MedicineCaregiver burdenMiddle Agedmedicine.diseaseCaregiverDistressNeurologyCaregivers030220 oncology & carcinogenesisFrontotemporal DementiaSurgeryDementiaFemaleNeurology (clinical)Alzheimer's diseasebusiness030217 neurology & neurosurgeryClinical psychology
researchProduct

Lanreotide Therapy vs Active Surveillance in MEN1-Related Pancreatic Neuroendocrine Tumors2 Centimeters.

2019

Abstract Purpose Pancreatic neuroendocrine tumors (pNETs) are frequent in multiple endocrine neoplasia type 1 (MEN1) syndrome. They are usually not surgically treated unless larger than 1 to 2 cm or a growth rate > 0.5 cm per year. Somatostatin analogues represent one of the main therapeutic options in pNETs, but they have never been prospectively investigated in MEN1-related pNETs. The aim of this study was to prospectively evaluate the effectiveness of lanreotide in patients with MEN1-related pNETs < 2 cm. Methods MEN1 patients with 1 or more pNETs < 2 cm of maximal diameter were considered. Study design was prospective observational, comparing patients treated with l…

MaleEndocrinology Diabetes and MetabolismClinical BiochemistryNeuroendocrine tumorsLanreotideBiochemistryGastroenterologychemistry.chemical_compoundEndocrinologyactive surveillance lanreotide MEN1 pancreatic neuroendocrine tumors somatostatin analoguesProspective StudiesProspective cohort studyMultiple endocrine neoplasiasomatostatin analoguesMiddle AgedPrognosisTumor BurdenNeuroendocrine TumorsSomatostatinMEN1Disease ProgressionFemalelanreotideSomatostatinAdultmedicine.medical_specialtyAntineoplastic Agentspancreatic neuroendocrine tumorPeptides CyclicYoung AdultInternal medicinemedicineMultiple Endocrine Neoplasia Type 1HumansMEN1Watchful WaitingAgedCentimeterpancreatic neuroendocrine tumorsbusiness.industryBiochemistry (medical)active surveillancemedicine.diseasePancreatic NeoplasmsEndocrinologychemistryactive surveillance; lanreotide; MEN1; pancreatic neuroendocrine tumors; somatostatin analoguesTumor progressionCase-Control StudiesbusinessFollow-Up StudiesThe Journal of clinical endocrinology and metabolism
researchProduct